Profile Previews

Get a glimpse into our company and investor data—powered by the PitchBook Platform

Mariposa Health

Mariposa Health
2008 FOUNDED
M&A STATUS
M&A LATEST DEAL TYPE
2 FINANCING ROUNDS
Description

Provider of health and pharmaceutical research and development services intended to focus on the development and commercialisation of treatments for conditions causing chronically poor airflow to the lungs. The company's health and pharmaceutical research and development services include a novel anti-inflammatory/anti-oxidant and an oral bacterial vaccine, form our two-pronged complementary approach to the treatment of Chronic Obstructive Pulmonary Disease (COPD) from its early to severe stages enabling patients to get products for undertreated conditions, primarily those of the airways from the mouth and nose to the lungs.

Ownership Status
Acquired/Merged
(Operating Subsidiary)
Financing Status
Corporate Backed or Acquired
Primary Industry
Biotechnology
Other Industries
Pharmaceuticals
Drug Discovery
Parent Company
Mariposa Health US
Primary Office
  • 61 Avalon Parade
  • Unit 6
  • Avalon Beach, New South Wales 2107
  • Australia

Mariposa Health Valuation and Funding

Deal Type Date Amount Post-Val Valuation/
EBITDA
Debt Status

This information is reserved for PitchBook Platform users. To explore Mariposa Health‘s full profile, request access.

Request full access to PitchBook

Mariposa Health Executive Team (1)

Name Title Board
Seat
Contact
Info
Phillip Comans Managing Director, Executive Chairman, Founder & President

Mariposa Health Board Members (1)

Name Representing Role Since Contact
Info
0000000 000000 Mariposa Health Managing Director, Executive Chairman, Founder & President 000 0000